Sykehuset Ostfold HF

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Immune thrombocytopenia (ITP)3 trials
• Depression2 trials
• Aortic stenosis1 trial
• COPD1 trial
• Dermatomyositis and polymyositis (myositis)1 trial
• Familial hypercholesterolaemia1 trial
• Glioblastoma1 trial
• Heart failure1 trial
• IgA nephropathy1 trial
• Lung cancer1 trial
• Stroke1 trial

Phase

• Phase 39 trials
• Phase 22 trials
• Phase 11 trial
• Phase 2/31 trial

Status

• Recruiting6 trials
• Not yet recruiting3 trials
• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Takeda3 trials
• Ostfold Hospital Trust2 trials
• AstraZeneca1 trial
• Boehringer Ingelheim1 trial
• Bristol-Myers Squibb1 trial
• and 5 more

Running trials

• Not yet recruiting

  A Randomized, Delayed-Treatment Controlled, Phase 2 Pilot Study of Manualized MDMA-Assisted Therapy for Young Adults with Chronic Treatment-Resistant Major Depressive Disorder

  2024-520319-42-01· Phase 2· Ostfold Hospital Trust· Source

• Recruiting

  Ketamine maintenance treatment for depression: A multicenter open-label randomized controlled trial (PreKET)

  2025-521330-29-00· Phase 2· Ostfold Hospital Trust· Source

• Recruiting

  A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

  NCT07361510· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· Phase 3· Takeda· Source

• Recruiting

  Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

  NCT07001800· Phase 2/3· Kardigan, Inc.· Source

• Recruiting

  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  NCT06959095· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

  NCT07000136· Phase 3· AstraZeneca· Source

• Recruiting

  Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

  NCT06929806· Phase 3· Pharmacosmos A/S· Source

• Recruiting

  Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)

  2023-506998-35-00· Phase 3· Vaestra Goetalandsregionen· Source

• Recruiting

  Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  NCT06371417· Phase 1· Chugai Pharmaceutical· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting
• Aortic stenosis1 recruiting
• COPD1 recruiting
• Glioblastoma1 recruiting
• Heart failure1 recruiting
• IgA nephropathy1 recruiting
• Lung cancer1 recruiting
• Stroke1 recruiting

Closed trials

• Recruiting

  A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06948318· Phase 3· Takeda· Source

• Recruiting

  A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  NCT06722235· Phase 3· Takeda· Source